

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 9.95163774 |
| 2 | drug catabolic process (GO:0042737) | 9.37157765 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 8.44546957 |
| 4 | regulation of fibrinolysis (GO:0051917) | 8.35798412 |
| 5 | glyoxylate metabolic process (GO:0046487) | 8.20827511 |
| 6 | omega-hydroxylase P450 pathway (GO:0097267) | 8.19905061 |
| 7 | negative regulation of fibrinolysis (GO:0051918) | 8.14632231 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 7.25503741 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.25503741 |
| 10 | complement activation, alternative pathway (GO:0006957) | 7.09573867 |
| 11 | fibrinolysis (GO:0042730) | 6.92624939 |
| 12 | regulation of protein activation cascade (GO:2000257) | 6.91764481 |
| 13 | urea metabolic process (GO:0019627) | 6.79040260 |
| 14 | cellular glucuronidation (GO:0052695) | 6.67043931 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.62046147 |
| 16 | L-phenylalanine metabolic process (GO:0006558) | 6.62046147 |
| 17 | bile acid biosynthetic process (GO:0006699) | 6.53948865 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.50219388 |
| 19 | regulation of complement activation (GO:0030449) | 6.43371185 |
| 20 | ethanol oxidation (GO:0006069) | 6.39307874 |
| 21 | drug metabolic process (GO:0017144) | 6.37728824 |
| 22 | uronic acid metabolic process (GO:0006063) | 6.36954208 |
| 23 | glucuronate metabolic process (GO:0019585) | 6.36954208 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 6.22171520 |
| 25 | oxidative demethylation (GO:0070989) | 6.19609758 |
| 26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.14151287 |
| 27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.14151287 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.04765458 |
| 29 | protein carboxylation (GO:0018214) | 6.04765458 |
| 30 | blood coagulation, intrinsic pathway (GO:0007597) | 6.04296392 |
| 31 | negative regulation of cholesterol transport (GO:0032375) | 5.86509762 |
| 32 | negative regulation of sterol transport (GO:0032372) | 5.86509762 |
| 33 | bile acid metabolic process (GO:0008206) | 5.71870439 |
| 34 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.68442075 |
| 35 | urea cycle (GO:0000050) | 5.67640998 |
| 36 | aromatic amino acid family catabolic process (GO:0009074) | 5.62544358 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 5.59223394 |
| 38 | phenylpropanoid metabolic process (GO:0009698) | 5.56905139 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 5.33763820 |
| 40 | response to type I interferon (GO:0034340) | 5.20304288 |
| 41 | cellular response to type I interferon (GO:0071357) | 5.18133023 |
| 42 | type I interferon signaling pathway (GO:0060337) | 5.18133023 |
| 43 | glycine metabolic process (GO:0006544) | 5.17894566 |
| 44 | ethanol metabolic process (GO:0006067) | 5.15375712 |
| 45 | bile acid and bile salt transport (GO:0015721) | 5.06900463 |
| 46 | negative regulation of blood coagulation (GO:0030195) | 4.99728093 |
| 47 | negative regulation of hemostasis (GO:1900047) | 4.99728093 |
| 48 | S-adenosylmethionine metabolic process (GO:0046500) | 4.96339622 |
| 49 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.95321468 |
| 50 | regulation of plasminogen activation (GO:0010755) | 4.78516175 |
| 51 | amino-acid betaine metabolic process (GO:0006577) | 4.76220929 |
| 52 | alkaloid metabolic process (GO:0009820) | 4.70170194 |
| 53 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.63551422 |
| 54 | protein activation cascade (GO:0072376) | 4.59760471 |
| 55 | triglyceride homeostasis (GO:0070328) | 4.58117526 |
| 56 | acylglycerol homeostasis (GO:0055090) | 4.58117526 |
| 57 | positive regulation of interferon-alpha production (GO:0032727) | 4.57095817 |
| 58 | negative regulation of coagulation (GO:0050819) | 4.53346565 |
| 59 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.50204356 |
| 60 | negative regulation of wound healing (GO:0061045) | 4.46357763 |
| 61 | response to interferon-alpha (GO:0035455) | 4.38571990 |
| 62 | imidazole-containing compound metabolic process (GO:0052803) | 4.35405181 |
| 63 | regulation of interferon-alpha production (GO:0032647) | 4.34928654 |
| 64 | phospholipid efflux (GO:0033700) | 4.32777488 |
| 65 | regulation of humoral immune response (GO:0002920) | 4.22137394 |
| 66 | hormone catabolic process (GO:0042447) | 4.21736752 |
| 67 | complement activation (GO:0006956) | 4.17822325 |
| 68 | tryptophan catabolic process (GO:0006569) | 4.17691573 |
| 69 | indole-containing compound catabolic process (GO:0042436) | 4.17691573 |
| 70 | indolalkylamine catabolic process (GO:0046218) | 4.17691573 |
| 71 | heme transport (GO:0015886) | 4.16161098 |
| 72 | regulation of RIG-I signaling pathway (GO:0039535) | 4.15418924 |
| 73 | positive regulation of hemostasis (GO:1900048) | 4.15334616 |
| 74 | positive regulation of blood coagulation (GO:0030194) | 4.15334616 |
| 75 | arginine metabolic process (GO:0006525) | 4.15132496 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 4.11670131 |
| 77 | negative regulation of protein activation cascade (GO:2000258) | 4.08939727 |
| 78 | tyrosine metabolic process (GO:0006570) | 4.06415668 |
| 79 | complement activation, classical pathway (GO:0006958) | 4.06104903 |
| 80 | acute-phase response (GO:0006953) | 4.05617188 |
| 81 | T cell migration (GO:0072678) | 4.05375909 |
| 82 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.03985087 |
| 83 | response to interferon-beta (GO:0035456) | 3.94391700 |
| 84 | cholesterol efflux (GO:0033344) | 3.94061674 |
| 85 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.91947304 |
| 86 | defense response to protozoan (GO:0042832) | 3.89739082 |
| 87 | plasma lipoprotein particle remodeling (GO:0034369) | 3.87614374 |
| 88 | protein-lipid complex remodeling (GO:0034368) | 3.87614374 |
| 89 | macromolecular complex remodeling (GO:0034367) | 3.87614374 |
| 90 | negative regulation of lipase activity (GO:0060192) | 3.87110101 |
| 91 | high-density lipoprotein particle remodeling (GO:0034375) | 3.86991727 |
| 92 | cellular response to interferon-beta (GO:0035458) | 3.86557077 |
| 93 | steroid catabolic process (GO:0006706) | 3.84366247 |
| 94 | positive regulation of coagulation (GO:0050820) | 3.84283223 |
| 95 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.83519342 |
| 96 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.83519342 |
| 97 | immunoglobulin mediated immune response (GO:0016064) | 3.82287111 |
| 98 | intestinal cholesterol absorption (GO:0030299) | 3.81337768 |
| 99 | alpha-amino acid catabolic process (GO:1901606) | 3.80399319 |
| 100 | flavonoid metabolic process (GO:0009812) | 3.75336406 |
| 101 | positive regulation by symbiont of host defense response (GO:0052509) | 3.75309498 |
| 102 | modulation by symbiont of host defense response (GO:0052031) | 3.75309498 |
| 103 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.75309498 |
| 104 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.75309498 |
| 105 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.75309498 |
| 106 | modulation by symbiont of host immune response (GO:0052553) | 3.75309498 |
| 107 | xenobiotic metabolic process (GO:0006805) | 3.74364753 |
| 108 | aromatic amino acid family metabolic process (GO:0009072) | 3.73457727 |
| 109 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.72752434 |
| 110 | neutrophil activation involved in immune response (GO:0002283) | 3.71706698 |
| 111 | negative regulation of viral genome replication (GO:0045071) | 3.70354089 |
| 112 | tryptophan metabolic process (GO:0006568) | 3.68585079 |
| 113 | cytolysis (GO:0019835) | 3.68272387 |
| 114 | cellular ketone body metabolic process (GO:0046950) | 3.67529594 |
| 115 | L-methionine salvage (GO:0071267) | 3.66760583 |
| 116 | L-methionine biosynthetic process (GO:0071265) | 3.66760583 |
| 117 | amino acid salvage (GO:0043102) | 3.66760583 |
| 118 | regulation of cholesterol esterification (GO:0010872) | 3.64579443 |
| 119 | response to mercury ion (GO:0046689) | 3.64249906 |
| 120 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.62841257 |
| 121 | response to protozoan (GO:0001562) | 3.60217051 |
| 122 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.60160919 |
| 123 | daunorubicin metabolic process (GO:0044597) | 3.58710021 |
| 124 | polyketide metabolic process (GO:0030638) | 3.58710021 |
| 125 | doxorubicin metabolic process (GO:0044598) | 3.58710021 |
| 126 | primary alcohol catabolic process (GO:0034310) | 3.54475798 |
| 127 | sodium-independent organic anion transport (GO:0043252) | 3.54147725 |
| 128 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.54030067 |
| 129 | glutamate metabolic process (GO:0006536) | 3.53324186 |
| 130 | myeloid dendritic cell activation (GO:0001773) | 3.51712995 |
| 131 | negative regulation of complement activation (GO:0045916) | 3.50511321 |
| 132 | reverse cholesterol transport (GO:0043691) | 3.49441185 |
| 133 | regulation of gamma-delta T cell activation (GO:0046643) | 3.48496904 |
| 134 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.44183836 |
| 135 | T-helper 1 type immune response (GO:0042088) | 3.43981380 |
| 136 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.42874935 |
| 137 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.40868147 |
| 138 | cellular response to exogenous dsRNA (GO:0071360) | 3.39599922 |
| 139 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.35869192 |
| 140 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.34865535 |
| 141 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.30666281 |
| 142 | cellular extravasation (GO:0045123) | 3.29387947 |
| 143 | regulation of response to interferon-gamma (GO:0060330) | 3.29133834 |
| 144 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.27837141 |
| 145 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.23806422 |
| 146 | positive regulation of interferon-beta production (GO:0032728) | 3.23787417 |
| 147 | respiratory burst (GO:0045730) | 3.19688702 |
| 148 | mast cell activation (GO:0045576) | 3.19000559 |
| 149 | myeloid dendritic cell differentiation (GO:0043011) | 3.18951871 |
| 150 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.17441914 |
| 151 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.17234375 |
| 152 | response to peptidoglycan (GO:0032494) | 3.16846092 |
| 153 | cellular response to interferon-gamma (GO:0071346) | 3.13379299 |
| 154 | cellular response to interferon-alpha (GO:0035457) | 3.11743596 |
| 155 | B cell mediated immunity (GO:0019724) | 3.10104954 |
| 156 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.07721484 |
| 157 | positive regulation of B cell differentiation (GO:0045579) | 3.06325855 |
| 158 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.04887833 |
| 159 | cellular response to virus (GO:0098586) | 3.03896268 |
| 160 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.02647022 |
| 161 | positive regulation of humoral immune response (GO:0002922) | 3.02493707 |
| 162 | leukocyte aggregation (GO:0070486) | 3.01003758 |
| 163 | natural killer cell activation (GO:0030101) | 2.97880992 |
| 164 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.97020465 |
| 165 | natural killer cell mediated immunity (GO:0002228) | 2.97020465 |
| 166 | myeloid cell activation involved in immune response (GO:0002275) | 2.96404333 |
| 167 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.96304020 |
| 168 | positive regulation of antigen processing and presentation (GO:0002579) | 2.94289247 |
| 169 | cellular response to zinc ion (GO:0071294) | 2.92657491 |
| 170 | negative thymic T cell selection (GO:0045060) | 2.91398773 |
| 171 | defense response to virus (GO:0051607) | 2.90770897 |
| 172 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.89476554 |
| 173 | regulation of necroptotic process (GO:0060544) | 2.88266512 |
| 174 | regulation of chemokine biosynthetic process (GO:0045073) | 2.87711205 |
| 175 | interferon-gamma production (GO:0032609) | 2.87595168 |
| 176 | negative T cell selection (GO:0043383) | 2.87096227 |
| 177 | definitive hemopoiesis (GO:0060216) | 2.86248597 |
| 178 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.85890453 |
| 179 | positive regulation of B cell mediated immunity (GO:0002714) | 2.85890453 |
| 180 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.85770615 |
| 181 | NIK/NF-kappaB signaling (GO:0038061) | 2.83788416 |
| 182 | granulocyte activation (GO:0036230) | 2.83004036 |
| 183 | positive regulation of macrophage differentiation (GO:0045651) | 2.82850158 |
| 184 | macrophage activation involved in immune response (GO:0002281) | 2.82132902 |
| 185 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.80793750 |
| 186 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.80550218 |
| 187 | neutrophil activation (GO:0042119) | 2.79250517 |
| 188 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.79120072 |
| 189 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.79026984 |
| 190 | response to interferon-gamma (GO:0034341) | 2.78787185 |
| 191 | positive regulation of isotype switching (GO:0045830) | 2.77707862 |
| 192 | regulation of B cell differentiation (GO:0045577) | 2.77179301 |
| 193 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.74892796 |
| 194 | response to host immune response (GO:0052572) | 2.74892796 |
| 195 | response to muramyl dipeptide (GO:0032495) | 2.74879544 |
| 196 | B cell receptor signaling pathway (GO:0050853) | 2.73582741 |
| 197 | lymphocyte chemotaxis (GO:0048247) | 2.73464834 |
| 198 | positive regulation of defense response to virus by host (GO:0002230) | 2.73262710 |
| 199 | natural killer cell differentiation (GO:0001779) | 2.72907897 |
| 200 | positive regulation of interleukin-2 production (GO:0032743) | 2.71284755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.27121064 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.86825561 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.80356575 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.62907646 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.49960414 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.33536744 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.15516255 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.15417943 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.91917926 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.74394911 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.20552731 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.17228035 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.11039577 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.80106954 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.51747795 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.44315248 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.29536337 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.22456101 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.11706431 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.06424467 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.03467032 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.86569162 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.81486733 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.41369263 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.36860390 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.32584635 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 2.30507134 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 2.27201736 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.22640057 |
| 30 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.14511920 |
| 31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.12606997 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.11697382 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11693660 |
| 34 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.05756397 |
| 35 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.02467501 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 1.99999086 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.98439982 |
| 38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.96081044 |
| 39 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.88195536 |
| 40 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.87573657 |
| 41 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.84992292 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.83165876 |
| 43 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.79133711 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75338429 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.69253073 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68970638 |
| 47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.68812844 |
| 48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.65634251 |
| 49 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.61849435 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61660617 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.60487062 |
| 52 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.52586080 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52485094 |
| 54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48051842 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45969509 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45964143 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42097369 |
| 58 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.40947441 |
| 59 | UTX_26944678_Chip-Seq_JUKART_Human | 1.40257084 |
| 60 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.38920052 |
| 61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.38031899 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35757287 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34675979 |
| 64 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.34627927 |
| 65 | GATA3_26560356_Chip-Seq_TH2_Human | 1.32139873 |
| 66 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31843024 |
| 67 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.30642184 |
| 68 | MYC_22102868_ChIP-Seq_BL_Human | 1.29890223 |
| 69 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29408776 |
| 70 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28185600 |
| 71 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.26940451 |
| 72 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.26888450 |
| 73 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23313963 |
| 74 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21893860 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21208480 |
| 76 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.16986135 |
| 77 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15077356 |
| 78 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14845256 |
| 79 | MAF_26560356_Chip-Seq_TH2_Human | 1.13182318 |
| 80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.12631681 |
| 81 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.12551954 |
| 82 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.11562380 |
| 83 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.10407424 |
| 84 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.10079352 |
| 85 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10034093 |
| 86 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09708276 |
| 87 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09017470 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07943063 |
| 89 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06941569 |
| 90 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03626730 |
| 91 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.03541506 |
| 92 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.00864747 |
| 93 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00648155 |
| 94 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.00316678 |
| 95 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00143588 |
| 96 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.98527889 |
| 97 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97502386 |
| 98 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96723601 |
| 99 | AR_20517297_ChIP-Seq_VCAP_Human | 0.96238516 |
| 100 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93803187 |
| 101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92661728 |
| 102 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.92097960 |
| 103 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.91853248 |
| 104 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.90879662 |
| 105 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.90635032 |
| 106 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90118286 |
| 107 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88480240 |
| 108 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.88438719 |
| 109 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.86408346 |
| 110 | CBP_21632823_ChIP-Seq_H3396_Human | 0.85592045 |
| 111 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.84929196 |
| 112 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83759528 |
| 113 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.83586036 |
| 114 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83585462 |
| 115 | NFYA_21822215_ChIP-Seq_K562_Human | 0.83563906 |
| 116 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.82315430 |
| 117 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.82282992 |
| 118 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.81105344 |
| 119 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.80684563 |
| 120 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.80241044 |
| 121 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.77885272 |
| 122 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.77695111 |
| 123 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.77161728 |
| 124 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.76527509 |
| 125 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.76035815 |
| 126 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.75004108 |
| 127 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74128020 |
| 128 | GATA2_19941826_ChIP-Seq_K562_Human | 0.73834779 |
| 129 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.73226320 |
| 130 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.72521276 |
| 131 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.71945059 |
| 132 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71837206 |
| 133 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.71496720 |
| 134 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71181647 |
| 135 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.70451508 |
| 136 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.70107174 |
| 137 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.69499927 |
| 138 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.68619779 |
| 139 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.68444453 |
| 140 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.68231822 |
| 141 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.68162184 |
| 142 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.68000486 |
| 143 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.67958190 |
| 144 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67476612 |
| 145 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.66541337 |
| 146 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.66341163 |
| 147 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65880554 |
| 148 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65859597 |
| 149 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.65814558 |
| 150 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.64947776 |
| 151 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.64926416 |
| 152 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.64644198 |
| 153 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.64215998 |
| 154 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.64193227 |
| 155 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.63542949 |
| 156 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.63236387 |
| 157 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.63050864 |
| 158 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.62661253 |
| 159 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.62001543 |
| 160 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.60920173 |
| 161 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.60759828 |
| 162 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.60574587 |
| 163 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.60533400 |
| 164 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.60289665 |
| 165 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.60039958 |
| 166 | NFYB_21822215_ChIP-Seq_K562_Human | 0.60038993 |
| 167 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.59541413 |
| 168 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.59394337 |
| 169 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.58948342 |
| 170 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.58788564 |
| 171 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.58164942 |
| 172 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.58071599 |
| 173 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.57632659 |
| 174 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.57632659 |
| 175 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.56353615 |
| 176 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.56187166 |
| 177 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.55869089 |
| 178 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.55812283 |
| 179 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 0.55761777 |
| 180 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.55579417 |
| 181 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.55229109 |
| 182 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.54723918 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.75626555 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 6.13290207 |
| 3 | MP0005365_abnormal_bile_salt | 5.74893421 |
| 4 | MP0005360_urolithiasis | 5.70417507 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.47429980 |
| 6 | MP0003195_calcinosis | 5.02797795 |
| 7 | MP0001835_abnormal_antigen_presentation | 4.63297905 |
| 8 | MP0003252_abnormal_bile_duct | 4.02978914 |
| 9 | MP0009785_altered_susceptibility_to | 3.98574552 |
| 10 | MP0003724_increased_susceptibility_to | 3.72035914 |
| 11 | MP0003868_abnormal_feces_composition | 3.59339745 |
| 12 | MP0005671_abnormal_response_to | 3.53099270 |
| 13 | MP0001666_abnormal_nutrient_absorption | 3.29398655 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 3.09466985 |
| 15 | MP0005025_abnormal_response_to | 3.01368027 |
| 16 | MP0009697_abnormal_copulation | 2.99437905 |
| 17 | MP0003436_decreased_susceptibility_to | 2.94599521 |
| 18 | MP0000685_abnormal_immune_system | 2.94393692 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.93850291 |
| 20 | MP0001800_abnormal_humoral_immune | 2.85345835 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 2.77401752 |
| 22 | MP0005387_immune_system_phenotype | 2.76159791 |
| 23 | MP0001790_abnormal_immune_system | 2.76159791 |
| 24 | MP0006082_CNS_inflammation | 2.70902799 |
| 25 | MP0002452_abnormal_antigen_presenting | 2.67011771 |
| 26 | MP0002723_abnormal_immune_serum | 2.65390105 |
| 27 | MP0002419_abnormal_innate_immunity | 2.64293022 |
| 28 | MP0010329_abnormal_lipoprotein_level | 2.60686732 |
| 29 | MP0001819_abnormal_immune_cell | 2.45813524 |
| 30 | MP0002420_abnormal_adaptive_immunity | 2.44265804 |
| 31 | MP0003763_abnormal_thymus_physiology | 2.33377334 |
| 32 | MP0002876_abnormal_thyroid_physiology | 2.31102148 |
| 33 | MP0005464_abnormal_platelet_physiology | 2.22599290 |
| 34 | MP0002166_altered_tumor_susceptibility | 2.21148234 |
| 35 | MP0002006_tumorigenesis | 2.19401347 |
| 36 | MP0005332_abnormal_amino_acid | 2.17507757 |
| 37 | MP0003303_peritoneal_inflammation | 2.08703649 |
| 38 | MP0002398_abnormal_bone_marrow | 2.08023116 |
| 39 | MP0001853_heart_inflammation | 2.06184860 |
| 40 | MP0009840_abnormal_foam_cell | 2.05778317 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.99244943 |
| 42 | MP0000716_abnormal_immune_system | 1.96264555 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.91847672 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.91847672 |
| 45 | MP0004510_myositis | 1.88112356 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.85160252 |
| 47 | MP0002405_respiratory_system_inflammati | 1.84958695 |
| 48 | MP0002396_abnormal_hematopoietic_system | 1.82628544 |
| 49 | MP0004947_skin_inflammation | 1.82138289 |
| 50 | MP0004808_abnormal_hematopoietic_stem | 1.78355931 |
| 51 | MP0009764_decreased_sensitivity_to | 1.75568724 |
| 52 | MP0001764_abnormal_homeostasis | 1.70413616 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.68790111 |
| 54 | MP0009333_abnormal_splenocyte_physiolog | 1.67536050 |
| 55 | MP0008469_abnormal_protein_level | 1.66267910 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.64973436 |
| 57 | MP0002429_abnormal_blood_cell | 1.63260603 |
| 58 | MP0003300_gastrointestinal_ulcer | 1.63108243 |
| 59 | MP0002722_abnormal_immune_system | 1.62461980 |
| 60 | MP0002118_abnormal_lipid_homeostasis | 1.62259383 |
| 61 | MP0003448_altered_tumor_morphology | 1.60854293 |
| 62 | MP0009278_abnormal_bone_marrow | 1.43146351 |
| 63 | MP0000343_altered_response_to | 1.42612824 |
| 64 | MP0005058_abnormal_lysosome_morphology | 1.36700742 |
| 65 | MP0000703_abnormal_thymus_morphology | 1.27468484 |
| 66 | MP0000858_altered_metastatic_potential | 1.24737514 |
| 67 | MP0004019_abnormal_vitamin_homeostasis | 1.22079926 |
| 68 | MP0003191_abnormal_cellular_cholesterol | 1.20633254 |
| 69 | MP0001873_stomach_inflammation | 1.19653209 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 1.19016457 |
| 71 | MP0004782_abnormal_surfactant_physiolog | 1.17669063 |
| 72 | MP0005310_abnormal_salivary_gland | 1.15150725 |
| 73 | MP0009763_increased_sensitivity_to | 1.14948389 |
| 74 | MP0005408_hypopigmentation | 1.14261122 |
| 75 | MP0003866_abnormal_defecation | 1.14110277 |
| 76 | MP0002998_abnormal_bone_remodeling | 1.13201614 |
| 77 | MP0001661_extended_life_span | 1.13105405 |
| 78 | MP0003828_pulmonary_edema | 1.12443374 |
| 79 | MP0003075_altered_response_to | 1.11251352 |
| 80 | MP0010307_abnormal_tumor_latency | 1.09552772 |
| 81 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.08526275 |
| 82 | MP0005174_abnormal_tail_pigmentation | 1.06336296 |
| 83 | MP0001851_eye_inflammation | 1.04358433 |
| 84 | MP0003943_abnormal_hepatobiliary_system | 1.01883301 |
| 85 | MP0005451_abnormal_body_composition | 1.01446791 |
| 86 | MP0005166_decreased_susceptibility_to | 1.01374215 |
| 87 | MP0003186_abnormal_redox_activity | 1.00822182 |
| 88 | MP0000604_amyloidosis | 1.00029720 |
| 89 | MP0009053_abnormal_anal_canal | 0.98321520 |
| 90 | MP0006054_spinal_hemorrhage | 0.97144948 |
| 91 | MP0009643_abnormal_urine_homeostasis | 0.97120050 |
| 92 | MP0001879_abnormal_lymphatic_vessel | 0.89031806 |
| 93 | MP0000490_abnormal_crypts_of | 0.87833189 |
| 94 | MP0005376_homeostasis/metabolism_phenot | 0.84629611 |
| 95 | MP0002138_abnormal_hepatobiliary_system | 0.83896368 |
| 96 | MP0005167_abnormal_blood-brain_barrier | 0.83281959 |
| 97 | MP0000249_abnormal_blood_vessel | 0.83159648 |
| 98 | MP0005164_abnormal_response_to | 0.82690028 |
| 99 | MP0009642_abnormal_blood_homeostasis | 0.82189144 |
| 100 | MP0005390_skeleton_phenotype | 0.77126330 |
| 101 | MP0002933_joint_inflammation | 0.76420391 |
| 102 | MP0005075_abnormal_melanosome_morpholog | 0.75210844 |
| 103 | MP0003091_abnormal_cell_migration | 0.71724047 |
| 104 | MP0002019_abnormal_tumor_incidence | 0.71402663 |
| 105 | MP0005535_abnormal_body_temperature | 0.71359510 |
| 106 | MP0005395_other_phenotype | 0.71006540 |
| 107 | MP0002168_other_aberrant_phenotype | 0.70678459 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.70359488 |
| 109 | MP0005636_abnormal_mineral_homeostasis | 0.69972167 |
| 110 | MP0003172_abnormal_lysosome_physiology | 0.69820034 |
| 111 | MP0008872_abnormal_physiological_respon | 0.69284236 |
| 112 | MP0003566_abnormal_cell_adhesion | 0.69106489 |
| 113 | MP0010352_gastrointestinal_tract_polyps | 0.68614326 |
| 114 | MP0003045_fibrosis | 0.67935521 |
| 115 | MP0002877_abnormal_melanocyte_morpholog | 0.67676776 |
| 116 | MP0000015_abnormal_ear_pigmentation | 0.65406403 |
| 117 | MP0003638_abnormal_response/metabolism_ | 0.65222139 |
| 118 | MP0005266_abnormal_metabolism | 0.64458326 |
| 119 | MP0000569_abnormal_digit_pigmentation | 0.63795748 |
| 120 | MP0003011_delayed_dark_adaptation | 0.63537507 |
| 121 | MP0002136_abnormal_kidney_physiology | 0.63397502 |
| 122 | MP0005187_abnormal_penis_morphology | 0.62491604 |
| 123 | MP0010368_abnormal_lymphatic_system | 0.61260810 |
| 124 | MP0008874_decreased_physiological_sensi | 0.60429927 |
| 125 | MP0002095_abnormal_skin_pigmentation | 0.60289447 |
| 126 | MP0003279_aneurysm | 0.59538799 |
| 127 | MP0003879_abnormal_hair_cell | 0.58898311 |
| 128 | MP0002971_abnormal_brown_adipose | 0.58095403 |
| 129 | MP0001915_intracranial_hemorrhage | 0.58091510 |
| 130 | MP0000609_abnormal_liver_physiology | 0.57515838 |
| 131 | MP0000371_diluted_coat_color | 0.57295479 |
| 132 | MP0000598_abnormal_liver_morphology | 0.57090066 |
| 133 | MP0003656_abnormal_erythrocyte_physiolo | 0.56822510 |
| 134 | MP0002282_abnormal_trachea_morphology | 0.56746105 |
| 135 | MP0005023_abnormal_wound_healing | 0.55866126 |
| 136 | MP0003690_abnormal_glial_cell | 0.55702306 |
| 137 | MP0002132_abnormal_respiratory_system | 0.54359130 |
| 138 | MP0005319_abnormal_enzyme/_coenzyme | 0.54267739 |
| 139 | MP0003453_abnormal_keratinocyte_physiol | 0.53740628 |
| 140 | MP0002277_abnormal_respiratory_mucosa | 0.52966055 |
| 141 | MP0002078_abnormal_glucose_homeostasis | 0.51712072 |
| 142 | MP0005670_abnormal_white_adipose | 0.50773653 |
| 143 | MP0005334_abnormal_fat_pad | 0.48358211 |
| 144 | MP0004883_abnormal_blood_vessel | 0.45953345 |
| 145 | MP0006036_abnormal_mitochondrial_physio | 0.44965863 |
| 146 | MP0005448_abnormal_energy_balance | 0.34131535 |
| 147 | MP0008873_increased_physiological_sensi | 0.32865409 |
| 148 | MP0005647_abnormal_sex_gland | 0.32567934 |
| 149 | MP0004130_abnormal_muscle_cell | 0.31703553 |
| 150 | MP0002332_abnormal_exercise_endurance | 0.30507689 |
| 151 | MP0003959_abnormal_lean_body | 0.25065415 |
| 152 | MP0005084_abnormal_gallbladder_morpholo | 0.23751259 |
| 153 | MP0000920_abnormal_myelination | 0.22155421 |
| 154 | MP0005220_abnormal_exocrine_pancreas | 0.22118214 |
| 155 | MP0003718_maternal_effect | 0.21806313 |
| 156 | MP0003953_abnormal_hormone_level | 0.21406939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 9.04772578 |
| 2 | Complement deficiency (HP:0004431) | 8.33567862 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.66661747 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 7.52684113 |
| 5 | Conjugated hyperbilirubinemia (HP:0002908) | 6.76137124 |
| 6 | Abnormality of complement system (HP:0005339) | 6.70405038 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 5.42254184 |
| 8 | Eczematoid dermatitis (HP:0000976) | 5.32014025 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 5.31639830 |
| 10 | Recurrent abscess formation (HP:0002722) | 5.23270915 |
| 11 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.91261792 |
| 12 | Glomerulonephritis (HP:0000099) | 4.84985045 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 4.77069206 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.73586636 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.72613468 |
| 16 | Xanthomatosis (HP:0000991) | 4.67413223 |
| 17 | Chronic otitis media (HP:0000389) | 4.34919575 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 4.26687121 |
| 19 | Hypolipoproteinemia (HP:0010981) | 4.25549430 |
| 20 | Myositis (HP:0100614) | 4.17987430 |
| 21 | Recurrent bronchitis (HP:0002837) | 4.13484732 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.94458241 |
| 23 | Recurrent viral infections (HP:0004429) | 3.89492256 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 3.86583940 |
| 25 | Recurrent fungal infections (HP:0002841) | 3.83570465 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 3.79754308 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.78452481 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.74743683 |
| 29 | Generalized aminoaciduria (HP:0002909) | 3.74322821 |
| 30 | Fat malabsorption (HP:0002630) | 3.69254259 |
| 31 | Spontaneous abortion (HP:0005268) | 3.69135478 |
| 32 | Orchitis (HP:0100796) | 3.66042701 |
| 33 | Abnormality of T cell number (HP:0011839) | 3.63326429 |
| 34 | Nephritis (HP:0000123) | 3.58890542 |
| 35 | Vasculitis (HP:0002633) | 3.57859851 |
| 36 | Spontaneous hematomas (HP:0007420) | 3.56602359 |
| 37 | T lymphocytopenia (HP:0005403) | 3.54763733 |
| 38 | Optic neuritis (HP:0100653) | 3.54345594 |
| 39 | Retrobulbar optic neuritis (HP:0100654) | 3.54345594 |
| 40 | Abnormality of macrophages (HP:0004311) | 3.49229367 |
| 41 | Hyperglycinemia (HP:0002154) | 3.46921318 |
| 42 | Recurrent skin infections (HP:0001581) | 3.46165980 |
| 43 | Hyperammonemia (HP:0001987) | 3.43093637 |
| 44 | Cellulitis (HP:0100658) | 3.42771343 |
| 45 | Abnormality of T cells (HP:0002843) | 3.35176100 |
| 46 | IgM deficiency (HP:0002850) | 3.32732237 |
| 47 | Autoimmune hemolytic anemia (HP:0001890) | 3.32160911 |
| 48 | Increased IgM level (HP:0003496) | 3.29871296 |
| 49 | Recurrent cutaneous fungal infections (HP:0011370) | 3.26259728 |
| 50 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.26259728 |
| 51 | Rickets (HP:0002748) | 3.25861864 |
| 52 | Steatorrhea (HP:0002570) | 3.18711332 |
| 53 | Thrombocytosis (HP:0001894) | 3.17767039 |
| 54 | Agammaglobulinemia (HP:0004432) | 3.16656269 |
| 55 | Petechiae (HP:0000967) | 3.14046910 |
| 56 | Meningitis (HP:0001287) | 3.13057052 |
| 57 | Stomatitis (HP:0010280) | 3.07787000 |
| 58 | Abnormality of T cell physiology (HP:0011840) | 3.05880783 |
| 59 | Abnormality of the nasal mucosa (HP:0000433) | 3.05710081 |
| 60 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.05047658 |
| 61 | Abnormality of glycine metabolism (HP:0010895) | 3.05047658 |
| 62 | Osteomalacia (HP:0002749) | 3.03506999 |
| 63 | Prostate neoplasm (HP:0100787) | 3.03121230 |
| 64 | Systemic lupus erythematosus (HP:0002725) | 3.00399238 |
| 65 | Vacuolated lymphocytes (HP:0001922) | 2.99665198 |
| 66 | Prolonged bleeding time (HP:0003010) | 2.95497357 |
| 67 | Delayed CNS myelination (HP:0002188) | 2.94748778 |
| 68 | Reduced antithrombin III activity (HP:0001976) | 2.94688278 |
| 69 | Arterial thrombosis (HP:0004420) | 2.92493729 |
| 70 | Gingival bleeding (HP:0000225) | 2.92279884 |
| 71 | Nasal polyposis (HP:0100582) | 2.91586538 |
| 72 | Basal ganglia calcification (HP:0002135) | 2.90534500 |
| 73 | Periodontitis (HP:0000704) | 2.88007505 |
| 74 | Abnormality of the prostate (HP:0008775) | 2.87523512 |
| 75 | Abnormality of methionine metabolism (HP:0010901) | 2.87239361 |
| 76 | Hyperglycinuria (HP:0003108) | 2.84986756 |
| 77 | Thyroiditis (HP:0100646) | 2.80537637 |
| 78 | Hypercholesterolemia (HP:0003124) | 2.79455893 |
| 79 | Hemoptysis (HP:0002105) | 2.79209536 |
| 80 | Epistaxis (HP:0000421) | 2.77552841 |
| 81 | Vascular calcification (HP:0004934) | 2.76318015 |
| 82 | Gingivitis (HP:0000230) | 2.74300289 |
| 83 | Gastrointestinal infarctions (HP:0005244) | 2.74053359 |
| 84 | Obstructive lung disease (HP:0006536) | 2.73285017 |
| 85 | Chronic obstructive pulmonary disease (HP:0006510) | 2.73285017 |
| 86 | Pulmonary infiltrates (HP:0002113) | 2.72617459 |
| 87 | Hypergammaglobulinemia (HP:0010702) | 2.72408087 |
| 88 | Interstitial pulmonary disease (HP:0006530) | 2.72370571 |
| 89 | Abnormality of nucleobase metabolism (HP:0010932) | 2.71889779 |
| 90 | Pustule (HP:0200039) | 2.69594621 |
| 91 | Abnormality of serum amino acid levels (HP:0003112) | 2.69274080 |
| 92 | IgG deficiency (HP:0004315) | 2.68754849 |
| 93 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.68685461 |
| 94 | Leukocytosis (HP:0001974) | 2.67146281 |
| 95 | Hyperbilirubinemia (HP:0002904) | 2.66362591 |
| 96 | Chronic diarrhea (HP:0002028) | 2.66070161 |
| 97 | Hypoalphalipoproteinemia (HP:0003233) | 2.63728136 |
| 98 | Keratoconjunctivitis sicca (HP:0001097) | 2.62629913 |
| 99 | Fair hair (HP:0002286) | 2.62303576 |
| 100 | Mitral stenosis (HP:0001718) | 2.60549013 |
| 101 | Hemorrhage of the eye (HP:0011885) | 2.58084518 |
| 102 | IgA deficiency (HP:0002720) | 2.57027380 |
| 103 | Epidermoid cyst (HP:0200040) | 2.56629216 |
| 104 | Hematochezia (HP:0002573) | 2.54913137 |
| 105 | Inflammation of the large intestine (HP:0002037) | 2.53202376 |
| 106 | Lymphopenia (HP:0001888) | 2.52546223 |
| 107 | Purpura (HP:0000979) | 2.50425774 |
| 108 | Hyperphosphaturia (HP:0003109) | 2.47726691 |
| 109 | Eosinophilia (HP:0001880) | 2.47371923 |
| 110 | Abnormality of eosinophils (HP:0001879) | 2.46503911 |
| 111 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.46157582 |
| 112 | Joint hemorrhage (HP:0005261) | 2.45195671 |
| 113 | Osteomyelitis (HP:0002754) | 2.44194718 |
| 114 | Severe combined immunodeficiency (HP:0004430) | 2.43385517 |
| 115 | Colitis (HP:0002583) | 2.42787066 |
| 116 | Cardiovascular calcification (HP:0011915) | 2.42769557 |
| 117 | Combined immunodeficiency (HP:0005387) | 2.42298712 |
| 118 | Abnormality of the fingertips (HP:0001211) | 2.42071314 |
| 119 | Thrombophlebitis (HP:0004418) | 2.40576397 |
| 120 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.39662564 |
| 121 | Recurrent pneumonia (HP:0006532) | 2.38231755 |
| 122 | Menorrhagia (HP:0000132) | 2.37764456 |
| 123 | Chronic sinusitis (HP:0011109) | 2.37688005 |
| 124 | Keratoconjunctivitis (HP:0001096) | 2.37579492 |
| 125 | Gastrointestinal inflammation (HP:0004386) | 2.36916659 |
| 126 | Abnormality of B cell number (HP:0010975) | 2.34994072 |
| 127 | B lymphocytopenia (HP:0010976) | 2.34994072 |
| 128 | Hypoplasia of the thymus (HP:0000778) | 2.33254852 |
| 129 | Granulocytopenia (HP:0001913) | 2.32585545 |
| 130 | Glycosuria (HP:0003076) | 2.30035010 |
| 131 | Abnormality of urine glucose concentration (HP:0011016) | 2.30035010 |
| 132 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.27993981 |
| 133 | Abnormal gallbladder physiology (HP:0012438) | 2.27204722 |
| 134 | Cholecystitis (HP:0001082) | 2.27204722 |
| 135 | Encephalitis (HP:0002383) | 2.26719822 |
| 136 | Metabolic acidosis (HP:0001942) | 2.26433399 |
| 137 | Abnormality of vitamin metabolism (HP:0100508) | 2.26287858 |
| 138 | Joint swelling (HP:0001386) | 2.26257203 |
| 139 | Chest pain (HP:0100749) | 2.25928227 |
| 140 | Pulmonary embolism (HP:0002204) | 2.23509631 |
| 141 | Arthropathy (HP:0003040) | 2.22983764 |
| 142 | Ketosis (HP:0001946) | 2.22243841 |
| 143 | Hypochromic microcytic anemia (HP:0004840) | 2.21533173 |
| 144 | Recurrent lower respiratory tract infections (HP:0002783) | 2.20748596 |
| 145 | Bronchitis (HP:0012387) | 2.20474880 |
| 146 | Panhypogammaglobulinemia (HP:0003139) | 2.18469961 |
| 147 | Increased cerebral lipofuscin (HP:0011813) | 2.17384773 |
| 148 | Hepatocellular carcinoma (HP:0001402) | 2.16489943 |
| 149 | Thick nail (HP:0001805) | 2.16110969 |
| 150 | Irritability (HP:0000737) | 2.14469172 |
| 151 | Increased IgE level (HP:0003212) | 2.14371028 |
| 152 | Tetraparesis (HP:0002273) | 2.14018540 |
| 153 | Gastrointestinal stroma tumor (HP:0100723) | 2.13626411 |
| 154 | Urticaria (HP:0001025) | 2.08585458 |
| 155 | Neonatal hypoglycemia (HP:0001998) | 2.07868513 |
| 156 | Skin ulcer (HP:0200042) | 2.06864140 |
| 157 | Gangrene (HP:0100758) | 2.05128641 |
| 158 | Sepsis (HP:0100806) | 2.04258110 |
| 159 | Elevated alkaline phosphatase (HP:0003155) | 2.03983510 |
| 160 | Increased serum ferritin (HP:0003281) | 2.03868365 |
| 161 | Cholelithiasis (HP:0001081) | 2.03434160 |
| 162 | Myocardial infarction (HP:0001658) | 2.02363753 |
| 163 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 10.4981057 |
| 164 | Deep venous thrombosis (HP:0002625) | 10.2505583 |
| 165 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.99236804 |
| 166 | Abnormality of iron homeostasis (HP:0011031) | 1.97237113 |
| 167 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.94672461 |
| 168 | Increased mean platelet volume (HP:0011877) | 1.94103153 |
| 169 | Abnormal urine phosphate concentration (HP:0012599) | 1.93894224 |
| 170 | Abnormal gallbladder morphology (HP:0012437) | 1.93111667 |
| 171 | Abnormality of the Achilles tendon (HP:0005109) | 1.89900445 |
| 172 | Hypophosphatemic rickets (HP:0004912) | 1.89744311 |
| 173 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.87517661 |
| 174 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84549802 |
| 175 | Abnormal biliary tract physiology (HP:0012439) | 1.83876382 |
| 176 | Bile duct proliferation (HP:0001408) | 1.83876382 |
| 177 | Generalized hypopigmentation of hair (HP:0011358) | 1.83564313 |
| 178 | Bifid scrotum (HP:0000048) | 1.81658294 |
| 179 | Poikilocytosis (HP:0004447) | 1.80757061 |
| 180 | Lethargy (HP:0001254) | 1.80116314 |
| 181 | Abnormal platelet volume (HP:0011876) | 1.77403155 |
| 182 | Alkalosis (HP:0001948) | 1.75997879 |
| 183 | Hypochromic anemia (HP:0001931) | 1.75098415 |
| 184 | Pancreatitis (HP:0001733) | 1.75076525 |
| 185 | Hydroxyprolinuria (HP:0003080) | 1.73558293 |
| 186 | Abnormality of proline metabolism (HP:0010907) | 1.73558293 |
| 187 | Abnormality of purine metabolism (HP:0004352) | 1.71344273 |
| 188 | Cerebral edema (HP:0002181) | 1.70776670 |
| 189 | Anorexia (HP:0002039) | 1.65852323 |
| 190 | Atrioventricular block (HP:0001678) | 1.62205832 |
| 191 | Abnormal platelet function (HP:0011869) | 1.61105845 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.73237218 |
| 2 | TXK | 3.60288285 |
| 3 | MAP4K1 | 3.57764811 |
| 4 | BCKDK | 3.50150169 |
| 5 | TYK2 | 3.45326484 |
| 6 | IKBKE | 3.29812133 |
| 7 | JAK3 | 3.19175347 |
| 8 | TBK1 | 2.92811513 |
| 9 | IRAK4 | 2.63175781 |
| 10 | KIT | 2.63019297 |
| 11 | FGFR4 | 2.53932201 |
| 12 | JAK1 | 2.37621122 |
| 13 | BLK | 2.27109131 |
| 14 | PIK3CA | 2.23213251 |
| 15 | TEC | 2.14255999 |
| 16 | FGFR3 | 2.09291800 |
| 17 | ZAP70 | 1.98627877 |
| 18 | PRKACG | 1.94337177 |
| 19 | IKBKB | 1.91646142 |
| 20 | MAPKAPK3 | 1.82733478 |
| 21 | BTK | 1.80920888 |
| 22 | IRAK3 | 1.72714606 |
| 23 | PRPF4B | 1.70722714 |
| 24 | SIK1 | 1.67201663 |
| 25 | PIM2 | 1.66373430 |
| 26 | MAP3K13 | 1.59959059 |
| 27 | TGFBR2 | 1.55733506 |
| 28 | NEK9 | 1.54872427 |
| 29 | NME2 | 1.53411251 |
| 30 | PBK | 1.53004201 |
| 31 | ITK | 1.52758897 |
| 32 | RIPK4 | 1.51796601 |
| 33 | SYK | 1.51465481 |
| 34 | TIE1 | 1.44127915 |
| 35 | CHUK | 1.42744715 |
| 36 | MAP3K3 | 1.40555156 |
| 37 | LCK | 1.35377998 |
| 38 | GRK1 | 1.34561615 |
| 39 | TGFBR1 | 1.34196667 |
| 40 | STK10 | 1.32523196 |
| 41 | NLK | 1.32185918 |
| 42 | CSK | 1.30926145 |
| 43 | RPS6KA4 | 1.30860326 |
| 44 | PRKCG | 1.30792737 |
| 45 | RIPK1 | 1.30589252 |
| 46 | PRKAA2 | 1.25039311 |
| 47 | ERN1 | 1.24904091 |
| 48 | SCYL2 | 1.23427476 |
| 49 | EIF2AK1 | 1.22178296 |
| 50 | HCK | 1.21291980 |
| 51 | TAOK3 | 1.20738791 |
| 52 | PIM1 | 1.19972009 |
| 53 | TAOK2 | 1.19532209 |
| 54 | EPHB1 | 1.18575736 |
| 55 | CDK8 | 1.17819114 |
| 56 | MST4 | 1.14497464 |
| 57 | CAMKK2 | 1.13056142 |
| 58 | LYN | 1.11421572 |
| 59 | CSF1R | 1.11314603 |
| 60 | MAP2K3 | 1.09545273 |
| 61 | MAP2K4 | 1.06926425 |
| 62 | EIF2AK3 | 1.05666847 |
| 63 | JAK2 | 1.05306704 |
| 64 | KDR | 1.05054312 |
| 65 | DAPK2 | 1.03301769 |
| 66 | EPHA3 | 1.03036193 |
| 67 | SIK3 | 0.94917630 |
| 68 | CLK1 | 0.93582397 |
| 69 | PINK1 | 0.91597434 |
| 70 | STK4 | 0.90867488 |
| 71 | IRAK1 | 0.88913765 |
| 72 | FES | 0.87477771 |
| 73 | MAP3K11 | 0.86272576 |
| 74 | MARK3 | 0.83468504 |
| 75 | PRKG1 | 0.81351067 |
| 76 | EIF2AK2 | 0.80675598 |
| 77 | MATK | 0.80246015 |
| 78 | TRIB3 | 0.75991802 |
| 79 | FLT3 | 0.73767060 |
| 80 | BMPR2 | 0.72960901 |
| 81 | NTRK3 | 0.71902585 |
| 82 | PRKCZ | 0.71364099 |
| 83 | PRKACA | 0.70268566 |
| 84 | PDPK1 | 0.69212094 |
| 85 | CSNK1D | 0.68892345 |
| 86 | TRPM7 | 0.67383216 |
| 87 | PRKCB | 0.66658523 |
| 88 | LRRK2 | 0.66005818 |
| 89 | TNK2 | 0.65874966 |
| 90 | PRKCA | 0.65463118 |
| 91 | MAP3K10 | 0.65320148 |
| 92 | TESK2 | 0.65271732 |
| 93 | MAP3K12 | 0.64632013 |
| 94 | BCR | 0.64283308 |
| 95 | MAPK11 | 0.64174691 |
| 96 | MUSK | 0.63968828 |
| 97 | PRKCQ | 0.63111733 |
| 98 | EEF2K | 0.62491620 |
| 99 | MST1R | 0.61625281 |
| 100 | PKN2 | 0.60927074 |
| 101 | BMPR1B | 0.60508287 |
| 102 | DAPK1 | 0.59907705 |
| 103 | NUAK1 | 0.53503807 |
| 104 | PRKAA1 | 0.53202688 |
| 105 | MAPK7 | 0.51225621 |
| 106 | INSRR | 0.48830365 |
| 107 | BRD4 | 0.47330293 |
| 108 | ABL1 | 0.46692871 |
| 109 | CDK6 | 0.46027739 |
| 110 | MAP3K2 | 0.45929131 |
| 111 | ERBB2 | 0.44935165 |
| 112 | BRSK2 | 0.44925577 |
| 113 | PRKCD | 0.43909844 |
| 114 | RPS6KA5 | 0.43315914 |
| 115 | MAP3K6 | 0.43070051 |
| 116 | PDK2 | 0.41983519 |
| 117 | MAP3K5 | 0.41926505 |
| 118 | HIPK2 | 0.40169335 |
| 119 | SRC | 0.37621414 |
| 120 | GRK7 | 0.36310912 |
| 121 | FER | 0.36216161 |
| 122 | GRK6 | 0.36135929 |
| 123 | RPS6KA3 | 0.35534154 |
| 124 | GSK3A | 0.34982733 |
| 125 | EGFR | 0.34894026 |
| 126 | SMG1 | 0.34605841 |
| 127 | BMX | 0.33347090 |
| 128 | ADRBK2 | 0.32991315 |
| 129 | MAPK4 | 0.32977729 |
| 130 | MAPKAPK2 | 0.31576928 |
| 131 | RPS6KA6 | 0.31556075 |
| 132 | MYLK | 0.30390711 |
| 133 | IGF1R | 0.29610896 |
| 134 | IRAK2 | 0.29396462 |
| 135 | PRKCH | 0.29210574 |
| 136 | ACVR1B | 0.28725364 |
| 137 | SIK2 | 0.27779509 |
| 138 | FRK | 0.27508868 |
| 139 | PDK1 | 0.27493682 |
| 140 | CDK4 | 0.26065302 |
| 141 | ABL2 | 0.23798918 |
| 142 | ATR | 0.23621523 |
| 143 | CDK9 | 0.23552658 |
| 144 | MAPK3 | 0.21705913 |
| 145 | PIK3CG | 0.19835679 |
| 146 | MAPK12 | 0.18337379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.39748034 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.79187794 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.61352935 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.47025070 |
| 5 | Retinol metabolism_Homo sapiens_hsa00830 | 3.45609577 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 3.03651246 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.03534593 |
| 8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.98043446 |
| 9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.96014333 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.95460284 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.94128267 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.86077929 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.81693744 |
| 14 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.76885906 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.76120665 |
| 16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.75005136 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.67605234 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.62682508 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.61904741 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.61657590 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.57740561 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.42296246 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.42151329 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.30680975 |
| 25 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.26273442 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.21955151 |
| 27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.13159961 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.12332483 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.11424698 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.10112069 |
| 31 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.09094630 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 2.08303250 |
| 33 | Malaria_Homo sapiens_hsa05144 | 2.06838388 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 2.02884332 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.97896199 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.94355273 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 1.92637664 |
| 38 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.89231501 |
| 39 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.87664850 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.84824757 |
| 41 | Histidine metabolism_Homo sapiens_hsa00340 | 1.84484679 |
| 42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82405367 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.80725568 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.75323392 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.70792697 |
| 46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.70581052 |
| 47 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.67611271 |
| 48 | Asthma_Homo sapiens_hsa05310 | 1.67049114 |
| 49 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65623442 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.61055145 |
| 51 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.58861769 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.55289536 |
| 53 | Tuberculosis_Homo sapiens_hsa05152 | 1.55271050 |
| 54 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.50953590 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.50713192 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 1.46144953 |
| 57 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40767587 |
| 58 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.37330930 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.37214633 |
| 60 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.34303410 |
| 61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.31842349 |
| 62 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.31338491 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 1.30323833 |
| 64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.29300686 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 1.27021262 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 1.26880487 |
| 67 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.24345193 |
| 68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.23360127 |
| 69 | Hepatitis B_Homo sapiens_hsa05161 | 1.22717566 |
| 70 | Shigellosis_Homo sapiens_hsa05131 | 1.21686073 |
| 71 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19715018 |
| 72 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.19347695 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18632390 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.09731103 |
| 75 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.08979221 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.08065675 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.05761809 |
| 78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00452590 |
| 79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.98108303 |
| 80 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.92951271 |
| 81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.91094900 |
| 82 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.89669247 |
| 83 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.88956602 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88742757 |
| 85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.86591789 |
| 86 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.85250756 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | 0.83720509 |
| 88 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.82505591 |
| 89 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82418843 |
| 90 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.80576546 |
| 91 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.79441798 |
| 92 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.78189691 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77245237 |
| 94 | Carbon metabolism_Homo sapiens_hsa01200 | 0.76956648 |
| 95 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.76790513 |
| 96 | Lysosome_Homo sapiens_hsa04142 | 0.75373302 |
| 97 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72191151 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.70462373 |
| 99 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.67180542 |
| 100 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.65612070 |
| 101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65376510 |
| 102 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63704546 |
| 103 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.62287851 |
| 104 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58166355 |
| 105 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56987615 |
| 106 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56319579 |
| 107 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55840090 |
| 108 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54785980 |
| 109 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.53774467 |
| 110 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52094896 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51670113 |
| 112 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51634128 |
| 113 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51281153 |
| 114 | Lysine degradation_Homo sapiens_hsa00310 | 0.51006114 |
| 115 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50878556 |
| 116 | Amoebiasis_Homo sapiens_hsa05146 | 0.48956786 |
| 117 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.48102890 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46787101 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43906869 |
| 120 | ABC transporters_Homo sapiens_hsa02010 | 0.42515605 |
| 121 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41304639 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.38140705 |
| 123 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37693348 |
| 124 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37623497 |
| 125 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35823432 |
| 126 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34459783 |
| 127 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33889204 |
| 128 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33447070 |
| 129 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.31017253 |
| 130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30704160 |
| 131 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.28622569 |
| 132 | Prion diseases_Homo sapiens_hsa05020 | 0.27614537 |
| 133 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.26304785 |
| 134 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.26279750 |
| 135 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.26191935 |
| 136 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23718864 |
| 137 | Ribosome_Homo sapiens_hsa03010 | 0.22264388 |
| 138 | Base excision repair_Homo sapiens_hsa03410 | 0.22103520 |
| 139 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.19858406 |
| 140 | DNA replication_Homo sapiens_hsa03030 | 0.16468337 |
| 141 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.16439168 |
| 142 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.16269013 |
| 143 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.15277911 |
| 144 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.14983867 |
| 145 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.14614132 |
| 146 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.13592791 |
| 147 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.13060972 |
| 148 | Peroxisome_Homo sapiens_hsa04146 | 0.11531523 |
| 149 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.10148805 |
| 150 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.10044306 |
| 151 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.09978322 |
| 152 | Homologous recombination_Homo sapiens_hsa03440 | 0.08353812 |
| 153 | Prostate cancer_Homo sapiens_hsa05215 | 0.07744882 |
| 154 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.07458703 |
| 155 | Protein export_Homo sapiens_hsa03060 | 0.07192150 |
| 156 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.07008767 |
| 157 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.06845305 |
| 158 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.05850646 |
| 159 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.05419019 |
| 160 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.03042992 |
| 161 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.02809696 |
| 162 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.02219178 |
| 163 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2093551 |
| 164 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1947043 |
| 165 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1738810 |
| 166 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.1519497 |
| 167 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.1306335 |
| 168 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.1244783 |
| 169 | Mineral absorption_Homo sapiens_hsa04978 | -0.1064704 |
| 170 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1034966 |
| 171 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0634705 |
| 172 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0627608 |
| 173 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0580961 |
| 174 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0467533 |
| 175 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0202816 |

